InvestorsHub Logo
Followers 14
Posts 456
Boards Moderated 0
Alias Born 04/07/2013

Re: nutsyprofessor post# 24495

Sunday, 01/19/2014 4:57:40 PM

Sunday, January 19, 2014 4:57:40 PM

Post# of 425640
Nads: The FDA will approve Anchor with the following disclaimers:

Vascepa has not been tested nor has it been proven to Reduce CVE's...

In effect it will be approved to treat people with Trig's between 200 and 500 which is all Amarin's Joe Bruno said it is and was ever shooting for...

YOU ARE RIGHT: Anchor will NOT be approved to Reduce CVE's...

I spoke to Joe Bruno from Amarin who is their PR person at length just after the 16th of October because I wanted clarity as an Investor...

Why not give him a call Monday and take up a week or so of his time and ask him everything you are trying to "get across" here and then come back and give us an update to your position.

Here is his number: 1-908-719-1315

If it molds with Joe's then you are LONG. If it continues to not mold, then you must stay SHORT...

Or continue to HOLD your investment with an "80% chance of failure."


If that is the position you want to maintain, here is sound advise:

Sell now and go away, let the bad news hit, then re-buy and wait for Reduce-It.


In the meantime go to Joe for advise and please stop arguing with those here that know.

Our positions jive closely with Amarin's.

Anything else and you are just are just badgering people or you are certainly a closet short.


WHY ARGUE WITH US WHEN YOU SHOULD CALL JOE @ AMARIN and ARGUE WITH HIM?

He takes and returns ALL calls!




Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News